Sanofi - American Depositary Shares · Transaction Mar 30, 2026 · Filed Jul 21, 2026 · $15,001 to $50,000
Sanofi American Depositary Shares (Each representing one-half of one ordinary share)
Follow $SNY
One email when a member of Congress discloses a trade in it, with the official filing receipt linked.
Free. No account. Unsubscribe in one click.
Follow $SNY by emailVeridion Score
Why is SNY moving today?
Sanofi develops and markets drugs with a concentration in immunology, vaccines, and rare diseases. Although the company offers a diverse array of drugs, its highest-revenue product, Dupixent, accounts for over 30% of total sales. Profits for this immunology blockbuster drug are shared with Regeneron. About 45% of total revenue comes from the United States, 20% from Europe, and 6% from China.
Reported fields plus Veridion-computed history. Unsourced tiles are omitted.
SNY overview
Related filings and maps
Congress activity in SNY
13 filers · 10 buys · 13 sells (0 labeled S (partial)) · Nov 28, 2014 to Mar 30, 2026 · House 20 / Senate 3
All available history · Latest 5 of 23 lines · Read 2026-10-07T13:18:30.584Z
Sanofi - American Depositary Shares · Transaction Sep 11, 2025 · Filed Oct 22, 2025 · $1,001 to $15,000
Sanofi - American Depositary Shares · Transaction Aug 4, 2025 · Filed Sep 12, 2025 · $1,001 to $15,000
Sanofi - American Depositary Shares · Transaction Jul 22, 2025 · Filed Aug 13, 2025 · $1,001 to $15,000
Sanofi - American Depositary Shares · Transaction Jun 17, 2025 · Filed Aug 13, 2025 · $1,001 to $15,000
SNY contract awards, year to date.
Public federal awards linked to this ticker.
SNY lobbying filings, year to date.
Registered lobbying filings matched to Sanofi American Depositary Shares (Each representing one-half of one ordinary share).